Viatris (VTRS) Cash from Financing Activities (2019 - 2026)
Viatris (VTRS) posted Cash from Financing Activities of -$1.2 billion for Q2 2026, down 509.72% on a QoQ basis from -$203.8 million in Q1 2026, and down 242.88% year-over-year from $869.7 million in Q2 2025.
Powered by 
Analysis
Viatris (VTRS) Cash from Financing Activities (2019 - 2026) Analysis & Trends
Viatris has reported Cash from Financing Activities for 8 years, with the latest figure at -$1.2 billion in Q2 2026.
- On a quarterly basis, Cash from Financing Activities fell 242.88% year-over-year to -$1.2 billion in Q2 2026; TTM through Jun 2026 was -$1.9 billion, a 50.83% increase from a year earlier, with the FY2025 full-year figure at -$1.3 billion, up 70.12% from the prior year.
- Cash from Financing Activities was -$1.2 billion for Q2 2026 at Viatris, down from -$203.8 million in the prior quarter.
- The five-year high for Cash from Financing Activities was -$97.6 million in Q3 2023, with the low at -$1.6 billion in Q3 2024.
- Average Cash from Financing Activities over 5 years is -$736.1 million, with a median of -$769.2 million recorded in 2022.
- The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities soared 87.14% in 2023, then tumbled 1576.95% in 2024.
- Over 5 years, Cash from Financing Activities stood at -$1.3 billion in 2022, then soared by 30.4% to -$926.1 million in 2023, then tumbled by 53.35% to -$1.4 billion in 2024, then soared by 83.35% to -$236.4 million in 2025, then tumbled by 425.63% to -$1.2 billion in 2026.
- The last three Cash from Financing Activities figures came in at -$1.2 billion (Q2 2026), -$203.8 million (Q1 2026), and -$236.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 46.72 Bn | 43.07 Bn | 2.15 Bn | -1.00 Mn |
| 2 | Viatris | 19.64 Bn | 18.75 Bn | 1.46 Bn | -1.24 Bn |
| 3 | Dr Reddys Laboratories | 10.36 Bn | 10.22 Bn | 396.53 Mn | -75.18 Mn |
| 4 | Amneal Pharmaceuticals | 6.44 Bn | 6.39 Bn | 334.51 Mn | 79.36 Mn |
| 5 | Bausch Health Companies | 2.11 Bn | 1.24 Bn | 2.10 Bn | -49.00 Mn |
| 6 | Ani Pharmaceuticals | 1.88 Bn | 1.52 Bn | 165.89 Mn | -4.65 Mn |
| 7 | Alvotech | 1.83 Bn | 1.69 Bn | 2.56 Mn | 143.38 Mn |
| 8 | Amphastar Pharmaceuticals | 1.04 Bn | 751.07 Mn | 93.47 Mn | -43.54 Mn |
| 9 | Fennec Pharmaceuticals | 382.22 Mn | 340.97 Mn | 17.15 Mn | - |
| 10 | NutriBand | 94.45 Mn | 91.03 Mn | 181,874.00 | 430.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.24 Bn |
| Mar 31, 2026 | -203.80 Mn |
| Dec 31, 2025 | -236.40 Mn |
| Sep 30, 2025 | -228.10 Mn |
| Jun 30, 2025 | -362.40 Mn |
| Mar 31, 2025 | -467.00 Mn |
| Dec 31, 2024 | -1.42 Bn |
| Sep 30, 2024 | -1.64 Bn |
| Jun 30, 2024 | -847.90 Mn |
| Mar 31, 2024 | -425.60 Mn |
| Dec 31, 2023 | -926.10 Mn |
| Sep 30, 2023 | -97.60 Mn |
| Jun 30, 2023 | -303.50 Mn |
| Mar 31, 2023 | -974.70 Mn |
| Dec 31, 2022 | -1.33 Bn |
| Sep 30, 2022 | -758.70 Mn |
| Jun 30, 2022 | -779.60 Mn |
| Mar 31, 2022 | -1.01 Bn |
| Dec 31, 2021 | -349.20 Mn |
| Sep 30, 2021 | -877.50 Mn |
API Access
Viatris Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=VTRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "VTRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=VTRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();